Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
European Journal of Clinical Microbiology & Infectious Diseases
Metadata
Title
Irritable Bowel Syndrome in Patients with Blastocystis hominis Infection
Authors
A. Giacometti
O. Cirioni
A. Fiorentini
M. Fortuna
G. Scalise
Publication date
01-07-1999
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 6/1999
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s100960050314

Other articles of this Issue 6/1999

European Journal of Clinical Microbiology & Infectious Diseases 6/1999 Go to the issue

Note

Detection of Legionella DNA in Guinea Pig Peripheral Leukocytes, Urine and Plasma by the Polymerase Chain Reaction

Brief Reports

Candida Meningitis Possibly Resulting from a Harpoon Injury

Brief Reports

Lack of Association Between GBV-C Infection and Spontaneous Abortion

Article

Rare AIDS-Defining Diseases in the Swiss HIV Cohort Study

Note

Five-Year Analysis of Antimicrobial Susceptibility of the Streptococcus milleri Group

Note

Comparative Activity of 27 Antimicrobial Compounds Against 698 Streptococcus pneumoniae Isolates Originating from 20 European University Hospitals

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits